With CKAP4, PTX3, IGFBP2, and OPN all being able to accurately differentiate between AKI and chronic disease controls, it suggests that there is distinct proteomic regulation within AKI patients, which these proteins are able to accurately capture, allowing for clear differentiation. Here, IGFBP2 is linked to acute kidney injury.